ICRM
IDXX icon

Insight Capital Research & Management’s Idexx Laboratories IDXX Stock Holding History

Insight Capital Research & Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,913
Closed -$309K – 118
2017
Q2 		$309K Buy
+1,913
New +$311K 0.18% 100
2014
Q3 		– Sell
-6,100
Closed -$407K – 130
2014
Q2 		$407K Sell
6,100
-106
-2% -$6.74K 0.09% 111
2014
Q1 		$377K Sell
6,206
-330
-5% -$19.7K 0.09% 118
2013
Q4 		$348K Sell
6,536
-428
-6% -$22.5K 0.08% 132
2013
Q3 		$376K Sell
6,964
-1,934
-22% -$93K 0.09% 137
2013
Q2 		$399K Buy
+8,898
New +$389K 0.1% 159

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Insight Capital Research & Management's IDXX Position: Q3 2017 in Review

Insight Capital Research & Management sold out of Idexx Laboratories (IDXX) in Q3 2017, closing a stake of 1,913 shares — an estimated $309K sold.

Insight Capital Research & Management first reported a position in IDXX in Q2 2013 and held it in 6 quarters. The position peaked at $407K in Q2 2014. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • Insight Capital Research & Management reported no remaining Idexx Laboratories position as of Q3 2017 after selling out during the quarter.
  • Insight Capital Research & Management sold 1,913 Idexx Laboratories shares in Q3 2017, an estimated $309K.
  • Insight Capital Research & Management first reported a position in Idexx Laboratories in Q2 2013 and held it in 6 quarters.
  • Insight Capital Research & Management's Idexx Laboratories position peaked at $407K in Q2 2014.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on Insight Capital Research & Management's 13F filing for Q3 2017, filed 15 Nov 2017.